A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

Across nearly 2 million people with a mean age of 49, metabolic syndrome was tied to a 24% higher risk of all-cause ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

Mike Wood, the entrepreneur who created the massively popular LeapFrog toy company, died via physician-assisted suicide in ...

The total economic burden of Alzheimer's disease and related dementias in the United States will reach $781 billion this year ...

A study involving over 1,700 participants from five hospitals across Barcelona, Sweden, and Italy has confirmed the ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant ...

Microglia can be engineered to detect disease-specific brain changes – like amyloid plaques in Alzheimer’s disease – and ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study.